DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.
HPS Pharmacies wish to advise that Baxter is experiencing a supply interruption for Holoxan® vials as follows: Holoxan® Vials Ifosfamide 1g ARTG 43608 Holoxan® Vials Ifosfamide 2g ARTG 43609 Normal supplies of Holoxan® vials are expected to resume…
Read more
HPS Pharmacies wish to advise that Aspen is experiencing a supply interruption for Marcain® ampoules as follows: Marcain® 0.5% Ampoules Bupivacaine hydrochloride (as monohydrate) 100mg/20 mL ARTG 48328 Normal supplies are expected to resume from mid-July…
Read more
Further to DrugAlert vol 1039, HPS Pharmacies wish to advise that all brands are continuing to experience a supply interruption for salbutamol 5mg nebules as follows: Ventolin® Nebules Salbutamol 5mg/2.5mL ARTG 12534 Salbutamol Cipla Inhalation Ampoules…
Read more
HPS Pharmacies wish to give notice that Bayer is discontinuing the following contrast media products: Gastrografin® Oral Liquid Sodium amidotrizoate / amidotrizoate meglumine ARTG 10684 and 471827 Urografin® 10mL Ampoules Sodium amidotrizoate / amidotrizoate meglumine ARTG…
Read more
HPS Pharmacies wish to give notice that Cipla Australia, in consultation with the Therapeutic Goods Administration (TGA), has issued a drug recall for hydrocortisone vials as follows: Cipla Hydrocortisone Vials Hydrocortisone (as sodium succinate) 100 mg…
Read more
Further to DrugAlert vol 1040, HPS Pharmacies wish to provide an update on the availability of Prostin® E2 as follows: Prostin® E2 Vaginal Gel Dinoprostone 1mg ARTG 9983 Prostin® E2 Vaginal Gel Dinoprostone 2mg ARTG 9984 Normal supplies…
Read more
